Partner Courtenay Brinckerhoff was quoted in a June 14, 2013 Financial Times article titled, “Agricultural groups explore impact of ruling.” The article discussed the implications of the Supreme Court’s June 13, 2013 decision in the “ACLU/Myriad” gene patenting case (12-398, Association for Molecular Pathology v. Myriad Genetics, Inc.) on agricultural biotech companies. Manufacturers of GM seeds and altered plant material had thought themselves beyond the reach of Myriad, because they “believe their products have been changed enough to fall outside the judges’ definition of ‘products of nature.’” However, Ms. Brinckerhoff cautioned that, in light of Myriad and other recent decisions, companies should be proactive in reviewing patent portfolios as well as their legal position, and be prepared to take on new competitors. She stated, “It’s never crystal clear until you have the actual same facts decided.”
People
Related News
14 February 2025
In the News
Brian Wheeler Joins Podcast to Discuss Legal Journey
Foley & Lardner LLP partner Brian Wheeler joined the Hsu Untied podcast to discuss his legal career.
14 February 2025
In the News
Pavan Agarwal Featured in Leadership Q&A – 'Reflecting our firm’s core values drives me to do my best'
Foley & Lardner LLP partner Pavan Agarwal is featured by Law.com for his career journey, legal practice, and leadership in the article, “How I Made Practice Group Chair: ‘Keep Listening and Keep Learning,’ Says Pavan Agarwal of Foley & Lardner.”
14 February 2025
In the News
Judith Waltz on Trump Administration Deregulation Order, Impact on CMS
Foley & Lardner LLP partner Judith Waltz commented on the Trump administration's executive order requiring federal agencies cut ten regulations for each newly created one in the Modern Healthcare article, "CMS may evade Trump's sweeping deregulation order."